ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0835

Pathogenic Effect of Chronic Stress-induced interleukin-12/23p40 on Neuropsychiatric System in Lupus-prone Mouse

Nobuya Abe1, Kenji Oku1, Yuichiro Fujieda1, Nobuhiko Takahashi2, Kohei Karino1, Michihito Kono1, Masaru Kato1, Yuki Tanaka3, Rie Hasebe4, Olga Amengual1, Miwako Yamasaki5, Masahiko Watanabe5, Masaaki Murakami3 and Tatsuya Atsumi6, 1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan, 2Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 3Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan, 4Biomedical Animal Research Laboratory, Institute for Genetic Medicine, Hokkaido University, Sapporo, Hokkaido, Japan, 5Department of Anatomy, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan, 6Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapparo, Hokkaido, Japan

Meeting: ACR Convergence 2020

Keywords: Mouse Models, Lupus, neuropsychiatric disorders, Neuropsychiatry, sleep, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: SLE – Animal Models Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Neuropsychiatric system is one of the major organs affected in systemic lupus erythematosus (SLE). However, the pathogenesis of neuropsychiatric SLE (NPSLE) has not been fully established due to a variety of pathogenic pathways including thrombosis, autoantibodies, cytokines, and microglial activation leading to neuronal damage. Physiopsychological stress affects immune responses, putatively being a risk factor for the development of autoimmune diseases. Therefore, we have hypothesized an impact of physiopsychological stress on the pathogenesis of NPSLE, and analyzed stress-induced neuropsychiatric impairment in a murine model of lupus with the aim of establishing a novel therapeutic approach for NPSLE.

Methods: We placed chronic sleep disturbance (SD) stress for 2 weeks on 6-8-week-aged female MRL/lpr lupus prone mice and MRL/MpJ control mice using SD cage (Melquest, Japan). Open field (OF) test and elevated plus maze (EPM) test were used to assess anxiety-like behavior. We performed immunohistochemistry to evaluate neuronal and microglial activation, and Golgi-Cox staining to assess dendric morphological changes of neurons. Gene expression was comprehensively analyzed using RNA sequencing, and enzyme-linked immunoassay was used to evaluate interested protein level in cerebrospinal fluids (CSF) of the mice and of human including healthy controls and NPSLE patients.

Results: SD-subjected MRL/lpr exhibited less anxiety-like behavior than their counterparts in OF and EPM test, while control mice showed more anxiety when stressed. Stress activates ventral tegmental area, projecting medial prefrontal cortex (mPFC) and nucleus accumbens (NAcc). In the mPFC, SD-subjected MRL/lpr demonstrated significant numbers of phospho-cFos positive activated neuronal cells whereas both SD-subjected MRL/lpr and control mice contains higher number of such than SD-free mice in NAcc. Differential gene expressions of mPFC analyzed via RNA sequencing revealed that Il12b expression level was prominent in SD-subjected MRL/lpr. Il12b is reportedly expressed in microglia. We found that SD-subjected MRL/lpr had the highest numbers of activated microglia regarding the morphology and CD68 aggregation. The CSF level of interleukin (IL)-12/23p40 encoded by Il12b was the highest in SD-subjected MRL/lpr. Furthermore, NPSLE patients also showed higher CSF IL-12/23p40 levels than healthy controls and SLE patients without neuropsychiatric symptoms. In Golgi-Cox staining, the increased numbers of dendric spines in mPFC pyramidal neurons were observed only in SD-subjected MRL/lpr.

Conclusion: Physiopsychological stress induced abnormal behavior, microglial activation and elevated level of IL-12/23p40 in lupus model mice. Moreover, IL-12/23p40 in CSF was increased in NPSLE patients, possibly associated with the development of NPSLE. Our data indicates that IL-12/23p40 is a potential therapeutic target for NPSLE.


Disclosure: N. Abe, None; K. Oku, None; Y. Fujieda, None; N. Takahashi, None; K. Karino, None; M. Kono, GlaxoSmithKline K.K., 2; M. Kato, None; Y. Tanaka, None; R. Hasebe, None; O. Amengual, None; M. Yamasaki, None; M. Watanabe, None; M. Murakami, None; T. Atsumi, AbbVie Inc., 5, 8, 9, UCB Japan Co.,Ltd., 5, 8, Eisai Co., Ltd., 8, Gilead Sciences, Inc., 5, 8, Bristol Myers Squibb Co., 2, 8, Chugai Pharmaceutical Co., Ltd., 2, 8, 9, Mitsubishi Tanabe Pharma Corporation, 8, 9, Eli Lilly Japan K.K., 2, 5, 8, Astellas Pharma Inc., 8, 9, Pfizer Inc., 2, 8, 9, Daiichi Sankyo Company, Limited, 5, 8, 9.

To cite this abstract in AMA style:

Abe N, Oku K, Fujieda Y, Takahashi N, Karino K, Kono M, Kato M, Tanaka Y, Hasebe R, Amengual O, Yamasaki M, Watanabe M, Murakami M, Atsumi T. Pathogenic Effect of Chronic Stress-induced interleukin-12/23p40 on Neuropsychiatric System in Lupus-prone Mouse [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/pathogenic-effect-of-chronic-stress-induced-interleukin-12-23p40-on-neuropsychiatric-system-in-lupus-prone-mouse/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pathogenic-effect-of-chronic-stress-induced-interleukin-12-23p40-on-neuropsychiatric-system-in-lupus-prone-mouse/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology